SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001078782-12-001186
Filing Date
2012-05-02
Accepted
2012-05-01 20:38:22
Documents
1
Group Members
DERMASTAR INTERNATIONALMARK BAUMROBERT KAMMER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A f13da050112_13da.htm SC 13D/A 71822
  Complete submission text file 0001078782-12-001186.txt   73386
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83793 | Film No.: 12802417
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Filed by) CIK: 0001542484 (see all company filings)

Type: SC 13D/A